Clinical Trial Search

Primary: Self-reported Quit Attempts - The Primary Outcome is the Number of Veteran's Who Make a Self-reported Quit Attempt (as Defined as a 24-hour Point Prevalence Rate). — 34…

Primary: Change From Baseline to Week 24 in Disease Activity Score Based on 28-Joint Count (DAS28) — -1.56 scores on a scale

Primary: Time to Achieve Glycemic Control — 225 Minutes

Primary: The Prevalence of Incomplete Excision of Dysplasia at the Endocervical Excision Margin as Recognized Histologically. — 28; 39 participants

Primary: Uncorrected Decimal VA (5 m) — 48; 3; 1; 0 participants

Primary: Dosing Discrepancies Per 200 Dose Cycles: Dose Cycle Not Count — 2.05 discrepancies/200 dose cycles

Primary: Fetal Heart Activity 1 Month After Oocyte Retrieval — 0; 0 participants with fetal heart activity

Primary: Platelet Reactivity by VerifyNow P2Y12 — 188; 125; 228 PRU — p=0.017

Primary: Change in Average Central Corneal Curvature From Dispense at Week 1 — -0.44; -0.11 diopters

Primary: Mean Diurnal Intraocular Pressure (IOP) at Week 6 — 17.01; 20.37 mmHg

Primary: Percentage of Participants by Preferred Method of Drug Administration — 95.7; 87.4; 83.9; 88.5 percentage of participants

Primary: Extreme Risk: All-cause Death or Major Stroke; High Risk Surgical: All-cause Mortality — 26.0; 39.3; 14.1; 18.9 percentage of participants, Kaplan-Meier — p=<0.0001

Primary: Number of Patients With 15 or More Letter Improvement in Best Corrected Visual Acuity (BCVA) in the Study Eye — 60; 31 Patients

Primary: Change in the Average Pain Intensity Score on an 11-point Numeric Rating Scale (NRS-3) — -3.7; -2.7 units on a scale

Primary: Accurate Confirmation of Completed Abortion — 182; 164 participants — p=.13